Over the past eight weeks, we have been able to incorporate initial feedback thanks to demo presentations and evaluation phases with selected companies. We are therefore pleased to announce that we are now launching Docuply registration to all other interested parties from the pharmaceutical and biotech industry as part of our Open Beta Phase. The Open Beta phase will now remain active for over four months until April 28th, 2023, so that our features can be tested in detail. All participants who register for the Open Beat Phase now and make themselves available to us for feedback will be rewarded with credits for productive use of Docuply after the Open Beta Phase. No credit card or debit bank account is required to register.
Submit feedback (alternatively via the support button within the app)